About Wilbur Salt OS

We are building the first synthetic pharmaceutical enterprise—an AI-native operating system designed to act as an externally licensed cognition engine for the world's largest pharma companies.

About Salt AI

Salt AI is founded by industry veterans in high-performance computing (HPC), artificial intelligence, and life sciences. We are dedicated to building enterprise cognition engines that extend the cognitive capacity of pharmaceutical organizations—allowing them to think at a scale and speed previously impossible.

Our platform contains thousands of synthetic coworkers, each mapped to a defined domain role and governed by resume-driven execution protocols. These are not LLMs run wild, but structured agents bound by domain-specific job specs, methodological boundaries, and interaction standards.

Salt's architecture prioritizes model-agnostic orchestration—integrating best-in-class AI components and continuously swapping underperforming modules. The result is meaningful breakthroughs and competitive advantage for your organization.

Our Story

Bringing a new pharmaceutical product to market costs $1–2 billion and takes a decade or longer. Fewer than 5% of drug candidates achieve regulatory approval. The industry spends over $250 billion annually on R&D, yet attrition rates remain devastating at every stage.

Wilbur Salt OS was born from a simple observation: the pharmaceutical enterprise has become too complex for the human mind to model alone. Traditional consulting delivers static PowerPoints obsolete on delivery. Internal AI initiatives fare no better—70% of pharma digital projects fail to deliver real outcomes.

We built the V-Org Engine to bridge that gap. By creating a synthetic pharmaceutical enterprise—thousands of AI coworkers running in parallel to the real organization—we provide the "flight simulator" that executives have been missing. A new way to think in pharma organizations. One driven not by bandwidth, but by possibility.

Meet Our Team

Industry veterans in high-performance computing, artificial intelligence, and life sciences working together to build the first synthetic pharmaceutical enterprise.

AW

Aber Whitcomb

Chief Executive Officer, Co-Founder

Industry veteran in high-performance computing and artificial intelligence. Leading Salt AI's mission to build the first synthetic pharmaceutical enterprise.

JB

Jim Benedetto

Chief Technology Officer, Co-Founder

Expert in AI systems architecture and life sciences technology. Architecting the multi-agent simulation engine that powers thousands of synthetic coworkers.

CB

Charles Basil

Chief Financial Officer

Experienced financial leader with deep expertise in scaling technology companies. Overseeing Salt AI's financial strategy and operations.

NB

Nate Beyor

Chief Customer Officer

Dedicated to ensuring customer success and satisfaction. Building lasting partnerships with life sciences and healthcare organizations.

BB

Bob Battista

Head of Commercial

Leading commercial strategy and go-to-market initiatives. Driving adoption of Salt AI's solutions across the pharmaceutical industry.

JB

Josh Brooks

External Relations

Managing strategic partnerships and external communications. Building Salt AI's presence in the life sciences ecosystem.

RW

Ryan Wang

Chief Architect

Designing and building Salt AI's core platform architecture. Expert in scalable systems and AI infrastructure for enterprise cognition.

DS

Dan Sheikh

AI Solutions

Developing cutting-edge AI solutions for life sciences applications. Translating complex AI capabilities into practical business outcomes.

Strategic Advisors

Former CIO, Merck

Advising on enterprise data integration and security architecture.

Prof. of Complex Systems, MIT

Guiding the development of our core simulation algorithms.